Effect of Intermittent Oro-esophageal Tube Feeding on Dysphagic Patients With Parkinson Disease
NCT06206122 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2024-03-05
Summary
The goal of this or clinical trial is to explore Intermittent Oro-esophageal Tube Feeding vs. Nasogastric Tube Feeding on nutritional status, dysphagia, and activities of daily living in patients with Parkinson's disease. The main question it aims to answer are:
• Can stellate ganglion block improve the nutritional status, dysphagia, and activities of daily living in patients with Parkinson's disease, better than Nasogastric Tube Feeding.
Participants will be divided into the control group and observation group evenly. All the patients were provided with routine therapy and given nutritional support by Intermittent Oro-esophageal Tube Feeding and Nasogastric Tube Feeding respectively. The nutritional status, swallowing function, and activities of daily living of the two groups of patients before and after treatment were evaluated.
Conditions
- Parkinson Disease
Interventions
- DEVICE
-
Nasogastric tube
Besides, the control group was given enteral nutritional support with Nasogastric tube according to the relevant guidelines. Within 4 hours after admission, the placement of the feeding tube was conducted by professional medical staffs and after intubation, the tube was secured to the patient's cheek with medical tape. The feeding was conducted once every 3-4 hours, with 200-300ml each time. The total feeding volume was determined based on daily requirements. The feeding content was formulated by the nutritionists based on the patient's condition and relevant guidelines to reach the energy demand as 20-25 kcal/kg/day and protein supplementation of 1.2-2.0 g/kg/day for both two groups. For patients with limited tube feeding compliance, we made appropriate adjustments to ensure that they were not at risk of severe malnutrition as much as possible.
- DEVICE
-
Intermittent Oro-esophageal Tube
The observation group was given enteral nutritional support with Intermittent Oro-esophageal Tube according to the following procedure: Before each feeding, inside and outside of the tube was cleaned with water. During feeding, the patient should maintain a semi-reclining or sitting position with mouth opened, and the tube was inserted slowly and smoothly into the upper part of the esophagus by medical staffs while the appropriate depth of intubation was checked with the calibration markings on the tube wall. The distance from the incisors to the head part of the tube should be between 22-25 cm. However, the specific depth should be evaluated based on patients' feedback and adjusted accordingly. After insertion, the tail part of the tube should be put into a container full of water and the absence of continuous bubbles indicated a successful intubation. Then, the feeding was to be conducted three times per day with 50 ml per minute and 400-600ml for each feeding.
- BEHAVIORAL
-
Comprehensive rehabilitation training
1. Basic treatment, including corresponding control of risk factors and education on healthy lifestyles. 2. Swallowing training, including lemon ice stimulation, mendelson maneuver, empty swallowing training, and pronunciation training. 3. Pulmonary function training, including standing training, cough training, and diaphragm muscle training.
Sponsors & Collaborators
-
Zeng Changhao
lead OTHER
Principal Investigators
-
Sumei Wang, Master · Zhengzhou Tielu Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-05
- Primary Completion
- 2024-04-01
- Completion
- 2024-04-05
Countries
- China
Study Locations
More Related Trials
-
Neurostimulation for Dysphagia in Parkinson's Disease
NCT03253354 ·Status: COMPLETED ·Phase: NA
-
Innovative Treatments for Neurogenic Dysphagia
NCT07152899 ·Status: COMPLETED ·Phase: NA
-
A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Pallidotomy in the Treatment of Dyskinesia of Parkinson's Disease
NCT02003248 ·Status: COMPLETED ·Phase: PHASE1
-
Subthalamic Nucleus Versus Globus Pallidal Internus Deep Brain Stimulation for Parkinson Disease
NCT07250685 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
EMST and TMS for Treatment of Dysphagia in Parkinson's Disease
NCT02461082 ·Status: COMPLETED ·Phase: NA
-
Asymmetric Subthalamic Deep Brain Stimulation for Axial Motor Dysfunction in Parkinson's Disease
NCT03462082 ·Status: COMPLETED ·Phase: NA
-
Study of the Effects of STN-DBS on Gait in Parkinson's Disease.
NCT06418802 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease
NCT01736176 ·Status: COMPLETED ·Phase: PHASE3
-
Interleaving Stimulation Improves Dyskinesia in Parkinson's Disease
NCT06239454 ·Status: RECRUITING ·Phase: NA
-
Effect of Stellate Ganglion Block on Drooling in Parkinson's Syndrome
NCT06370195 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
NCT00143026 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion
NCT03602924 ·Status: UNKNOWN
-
Neurophysiological Characteristics of Subthalamic Deep-brain Stimulation (STN-DBS)
NCT04707638 ·Status: WITHDRAWN
-
The Study to Evaluate the Safety and Efficacy of Spinal Cord Stimulation on Progressive Supranuclear Palsy
NCT04367116 ·Status: TERMINATED ·Phase: NA
-
Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease
NCT05022147 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Effects of Resistant Starch on Bowel Habits, Fecal Short Chain Fatty Acids and Gut Microbiota in Parkinson Disease
NCT02784145 ·Status: COMPLETED ·Phase: NA
-
Effect of Deep Brain Stimulation on Gastrointestinal (GI) Motility
NCT01081457 ·Status: COMPLETED ·Phase: NA
-
Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease
NCT02112812 ·Status: COMPLETED ·Phase: NA
-
Asymmetric DBS for PD : A Multicenter, Prospective, Single Arm, Open Label Study
NCT04616521 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of Deep Brain Stimulation of Subthalamic Nucleus on the Hepatic Glucose Production in Parkinson's Disease
NCT00663312 ·Status: TERMINATED ·Phase: NA
-
Autologous Mesenchymal Stem Cell Transplant for Parkinson's Disease
NCT00976430 ·Status: TERMINATED ·Phase: NA
-
ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease
NCT02347254 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Deep Brain Stimulation and Digestive Symptomatology
NCT00639275 ·Status: COMPLETED
-
Deep Brain Stimulation Therapy and Intestinal Microbiota
NCT04855344 ·Status: UNKNOWN
-
A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension
NCT03462043 ·Status: WITHDRAWN ·Phase: PHASE3